Press releaseBusiness Wire
Precision BioSciences
DTIL · NASDAQ
$6.56+$0.37 (+5.98%)TodayMarket closed ·
Prev close $6.19
About DTIL
- Employees
- 68
- Headquarters
- Durham, North Carolina
- Listed
- Mar 28, 2019
- Sector
- Health Care
- Industry
- Biotechnology
- Website
- precisionbiosciences.com
DTIL key statistics
- Market cap
- 181.07M
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 267.27K
- Volume
- 213.67K
- Open price
- $6.19
- High today
- $6.67
- Low today
- $6.09
- 52 Week high
- $9.62
- 52 Week low
- $3.53
Precision BioSciences (DTIL) at a glance
Precision BioSciences (DTIL) last traded at $6.56, with a market cap of 181.07M and a price-to-earnings ratio of 0.00.
Today the stock has traded between $6.09 and $6.67. The current price is 7.7% above the day's low and 1.6% below its high.
Volume so far is 213.67K shares, below the average of 267.27K shares a day.
Over the past year Precision BioSciences has ranged from $3.53 to $9.62, and now sits 50% of the way up that range.
Precision BioSciences met or beat analyst EPS estimates in 1 of the last 8 quarters. In Q2 FY26 it reported -$1.26 per share against an estimate of -$0.8058.
The average analyst price target is $29.99, 357.1% above the current price, from 3 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
100%of 3 analyst ratings say Buy
- Buy100.0%
- Hold0.0%
- Sell0.0%
Price target · 7 analystsAvg $29.99
- Low
- $18.18
- Now
- $6.56
- High
- $63.00
DTIL earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 1 of the last 8 quarters, by 292.4% on average.
- Q3 FY24: reported -$2.25 per share against an estimate of -$1.96
- Q4 FY24: reported -$2.22 per share against an estimate of -$2.00
- Q1 FY25: reported -$2.21 per share against an estimate of -$1.75
- Q2 FY25: reported -$2.13 per share against an estimate of -$1.60
- Q3 FY25: reported -$1.84 per share against an estimate of -$1.37
- Q4 FY25: reported $1.05 per share against an estimate of -$0.5457
- Q1 FY26: reported -$0.75 per share against an estimate of -$0.6681
- Q2 FY26: reported -$1.26 per share against an estimate of -$0.8058
DTIL news
- Press releaseBusiness Wire
iECURE Presents Updated Clinical Data from OTC-HOPE Trial of ECUR-506 in Neonatal-Onset Ornithine Transcarbamylase Deficiency at SSIEM 2026
- Press releaseBusiness Wire
Precision BioSciences Commences Dosing in Phase 1/2 FUNCTION-DMD Study
- Press releaseBusiness Wire
iECURE to Present Clinical Data from Ongoing OTC-HOPE Trial of ECUR-506 in Neonatal-Onset Ornithine Transcarbamylase Deficiency at SSIEM Annual Symposium
- Press releaseBusiness Wire
Precision BioSciences Reports Second Quarter 2026 Financial Results and Provides Business Update
- Press releaseBusiness Wire
Precision BioSciences to Report Second Quarter 2026 Financial Results on August 6, 2026
- Press releaseBusiness Wire
Precision BioSciences Announces Changes to Senior Leadership Team to Support Advancement of Programs Through Next Set of Clinical Milestones
- Press releaseBusiness Wire
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.